Rituximab in the Treatment of Idiopathic Membranous Nephropathy

Clinical trial NCT00405340 · COMPLETED

Trial details

NCT number: NCT00405340
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Membranous Nephropathy

Start date: 2006-10-01
Primary completion: 2010-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.